Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
株式のランク #12604
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
株価
$9.09
最終同期: 2023-06-23
時価総額
$567.77M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 CTI BioPharma Corp. (CTIC)

カテゴリー

CTI BioPharma Corp.(CTIC)の株価履歴
終値の最高値: $9.07 (2023-06-01)

終値の最安値: $121.75K (1997-03-01)
CTI BioPharma Corp. の株価履歴(1997 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 59.07%
2022 173.23%
2021 -38.21%
2020 161.00%
2019 5.88%
2018 -53.69%
2017 -42.12%
2016 -61.16%
2015 -49.72%
2014 27.27%
2013 38.57%
2012 -76.52%
2011 -49.34%
2010 -67.69%
2009 680.34%
2008 -99.33%
2007 -70.14%
2006 -20.03%
2005 -71.45%
2004 -4.83%
2003 6.48%
2002 -68.99%
2001 -35.93%
2000 997.50%
1999 22.69%
1998 -81.36%
1997 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$755.62 6.68%
CH